These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9472602)

  • 1. Transdermal fentanyl and respiratory depression.
    McLoughlin R; McQuillan R
    Palliat Med; 1997 Sep; 11(5):419. PubMed ID: 9472602
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory arrest after cadaveric renal transplant.
    Hill LR; Pichel AC
    Eur J Anaesthesiol; 2009 May; 26(5):435-6. PubMed ID: 19521299
    [No Abstract]   [Full Text] [Related]  

  • 5. Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch.
    Hardwick WE; King WD; Palmisano PA
    South Med J; 1997 Sep; 90(9):962-4. PubMed ID: 9305315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal fentanyl (Duragesic): respiratory arrest in adolescents.
    Raymond B; Morawiecka I
    CMAJ; 2004 Oct; 171(8):991-2. PubMed ID: 15497207
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid-induced respiratory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD.
    Horton R; Barber C
    J Pain Symptom Manage; 2009 Jun; 37(6):e2-5. PubMed ID: 19500718
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe withdrawal from short-term transdermal fentanyl after naloxone for uremic pruritus.
    Finsterer J; Keller H; Arias I; Zuntner G
    J Pain Symptom Manage; 2004 May; 27(5):387-8. PubMed ID: 15120761
    [No Abstract]   [Full Text] [Related]  

  • 9. Exemplar: reversing respiratory depression.
    Farland A
    Nurs N Z; 2001 May; 7(4):21. PubMed ID: 12008508
    [No Abstract]   [Full Text] [Related]  

  • 10. Naloxone reversal of an overdose of a novel, long-acting transdermal fentanyl solution in laboratory Beagles.
    Freise KJ; Newbound GC; Tudan C; Clark TP
    J Vet Pharmacol Ther; 2012 Aug; 35 Suppl 2():45-51. PubMed ID: 22731775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Care of acute respiratory insufficiency due to etorphine intoxication treated by naloxone].
    Wang YP; Wang J
    Zhonghua Hu Li Za Zhi; 1996 Oct; 31(10):591-2. PubMed ID: 9295537
    [No Abstract]   [Full Text] [Related]  

  • 12. Suspected respiratory depression associated with use of transdermal fentanyl patch.
    Matsuki Y; Mizogam M; Tabata M; Matsuki Y; Yasuda Y; Shigemi K
    Pain Physician; 2012; 15(4):E536-7. PubMed ID: 22828702
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss of gag reflex and swallowing ability after administration of intrathecal fentanyl.
    Smiley RM; Moore RP
    Anesthesiology; 2007 Jun; 106(6):1253. PubMed ID: 17525617
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe respiratory depression and sedation with transdermal fentanyl: four case studies.
    Regnard C; Pelham A
    Palliat Med; 2003 Dec; 17(8):714-6. PubMed ID: 14694924
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of naloxone to antagonize large doses of opiates administered during nitrous oxide anesthesia.
    Heisterkamp DV; Cohen PJ
    Anesth Analg; 1974; 53(1):12-8. PubMed ID: 4855701
    [No Abstract]   [Full Text] [Related]  

  • 16. [Respiratory depression caused by a fentanyl patch applied as a topical analgesic].
    Myllärniemi M; Kauppi P
    Duodecim; 2014; 130(17):1759-60. PubMed ID: 25272787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
    Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl patch abuse: naloxone complications and extracorporeal membrane oxygenation rescue.
    Pizon AF; Brooks DE
    Vet Hum Toxicol; 2004 Oct; 46(5):256-7. PubMed ID: 15487648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
    Arpino PA; Thompson BT
    J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cancer pain.
    Flores C
    JAMA; 2004 Mar; 291(9):1068; author reply 1068-9. PubMed ID: 14996774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.